KIDS
Orthopediatrics Corp
22.90$
+3.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.5% | -0.4% | -1.5% | +13.6% | -3.3% | -0.6% | +7.1% | -2.0% | +3.1% | -1.3% | +1.8% | |
| – | +0.1% | -10.1% | -4.9% | +28.1% | -4.5% | -2.2% | +11.1% | -4.6% | +4.3% | -4.1% | +2.7% | |
| – | +191.9% | -30.4% | +33.9% | +76.5% | -14.2% | -23.7% | +33.2% | -62.2% | +16.2% | -27.2% | +19.3% | |
| – | -2.6% | -40.5% | -39.4% | +163.0% | -9.5% | -14.6% | +19.4% | -17.7% | +5.4% | -16.4% | -9.8% | |
| – | -8.0% | +4.8% | +15.9% | +1.9% | -1.1% | +3.9% | +22.3% | -4.7% | +5.0% | +1.1% | +12.0% | |
| – | +5.3% | +6.5% | +3.3% | +3.9% | -3.2% | +2.3% | +4.6% | +2.8% | +3.9% | +0.2% | +2.6% | |
| – | +3.5% | +9.3% | -1.1% | +0.8% | +2.8% | -0.2% | +5.7% | +4.6% | +5.5% | +5.4% | +2.9% | |
| – | +0.0% | +5.5% | -3.0% | -2.1% | -4.2% | -2.6% | +1.2% | -1.0% | -1.9% | -1.3% | -0.2% | |
| – | +6.2% | +7.9% | -10.7% | +99.1% | +0.2% | +3.8% | +20.3% | -2.6% | +12.4% | +0.9% | +2.6% | |
| – | -13.1% | +10.0% | -13.6% | -12.5% | -1.9% | +10.4% | +3.1% | -14.1% | +39.0% | +2.1% | +12.0% | |
| – | +1.3% | +277.6% | +128.4% | +47.3% | +18.1% | -92.9% | +1.2% | +1.2% | +2.4% | +1,623.5% | -94.1% | |
| – | -44.0% | +56.0% | -13.9% | -31.5% | -23.5% | +59.4% | -10.6% | -43.5% | +162.2% | +4.9% | +12.9% | |
| – | +1,424.3% | +2.5% | -3.6% | +641.3% | +0.6% | +0.1% | +32.8% | +2.2% | +0.7% | +0.6% | -0.9% | |
| – | +0.7% | -1.7% | +0.2% | -0.1% | -4.4% | -2.1% | +2.4% | -1.7% | -0.8% | -2.3% | +1.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +0.3% | +1.4% | +0.1% | +0.0% | +0.3% | +0.5% | +0.3% | +0.7% | +0.5% | +0.8% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.